| IPO Company Profile © ipodata.com |
| Message Board | SEC Filings | Peer IPO Companies |
| GMP Companies, Inc. |
| One East Broward Boulevard, Suite 1701, Fort Lauderdale, FL 33301 * (954) 745-3510 |
| Business Description | The company identifies, acquires, develops and commercials innovative medical technologies for the health care market. |
|
Filing Information Not yet | |||
| To Trade As | GMPC (NASNTL) | Industry | Service (SIC 8731) |
| Type of Stock Offered | Common Shares | Filing Date | 11/7/00 |
| Domestic Shares Filed | 0 | Filing Price | - - |
| Foreign Shares Filed | 0 | Offering Amount | $150,000,000 |
| Company Shares | 0 | Est. Expenses | - - |
| Selling Shrhldrs Shares | 0 | Post-IPO Shares | - - |
| Primary Underwriting Group | ||
| Underwriter Name | Participation | Underwriter Phone |
| Salomon Smith Barney | Lead Manager | (212) 723-7300 |
| CS First Boston | Co-manager | (212) 325-2000 |
| Income Statement and Cash Flow Summary | |||||||
| Prior Audited Income |
Latest Unaudited Income | ||||||
| Full Year Audited Figures | 9 Months Ending | ||||||
| Figures in U.S. millions except per share data | 12/31/99 | 9/30/00 | |||||
| Revenues | - | - | - | - | 0.000 | - | 0.015 |
| Income from Oper. | - | - | - | - | -4.596 | - | -19.859 |
| Net Income | - | - | - | - | -4.160 | - | -16.341 |
| E.P.S | - | - | - | - | -0.870 | - | -3.150 |
| Revenue Growth (%) | - | - | - | - | - | ||
| Net Income Growth (%) | - | - | - | - | - | ||
| Oper. Profit Margin (%) | - | - | - | - | - | - | - |
| Net Profit Margin (%) | - | - | - | - | - | - | - |
| Cash Flow - Oper. | -3.64 | - | - | ||||
| Cash Flow - Inv. | -6.76 | - | - | ||||
| Cash Flow - Fin. | 32.68 | - | - | ||||
| Balance Sheet Summary and Financial Ratios | |||||
| Balance sheet as of: 9/30/00 | Financial Ratios | ||||
| Total Assets | 121.07 | Current Assets | - | Current Ratio | - |
| Total Liab. | 5.94 | Current Liab. | - | Debt Ratio | 4.91% |
| Total Equity | 115.13 | Working Cap. | 111.61 | Debt to Equity Ratio | 0.05 |
| Cash | 114.56 | Return on Assets | - | ||
| Use Of Proceeds |
The proceeds from the proposed offering will be used to fund research and development, commercialization of products, the acquisition of new technologies and for other general corporate purposes. |
| Legal Counsel Registrar Auditor | |
| Issuer's Law Firm | Greenberg Traurig Hoffman Lipoff Rosen & Quentel |
| Bank's Law Firm | Cravath, Swaine & Moore |
| Registrar/Transfer Agent | American Stock Transfer & Trust Co |
| Auditor | Ernst & Young |
| Send us feedback if you would like to request that we hyperlink a firm on this page | |
| Principal Shareholders | ||
| Name of Shareholder | % Owned Before | % Owned After |
| Seligman Funds | 15.10 | |
| Motorola, Inc. | 13.10 | |
| Texas Pacific Group | 12.90 | |
| Note: represents ownership of 5% or more prior to the offering. | ||